Myopic Chorioretinal Atrophy: Clinical Trials

1 trial for Myopic Chorioretinal Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1

Follow Myopic Chorioretinal Atrophy: new trials by email Literature Review of Myopic Chorioretinal Atrophy trials Research Report on Myopic Chorioretinal Atrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)
Pars plana vitrectomy - Myopic Chorioretinal Atrophy
Not applicableActive not recruitingPharmaBio Corporation102023-02-172026-09-29

Sponsors

PharmaBio Corporation (1)

Countries

Japan (1)

Top investigators

Hitoshi Kusano, M.D. (1)

Results publications

PMID 39716323